Publications
2024
Vitamin D and cardiovascular outcomes in multiple sclerosis.
France-Ratcliffe, M., Harrison, S. L., Verma, L. A., Abdul-Rahim, A. H., McCallum, L., Young, C. A., . . . Buckley, B. J. (2024). Vitamin D and cardiovascular outcomes in multiple sclerosis.. Multiple sclerosis and related disorders, 92, 106155. doi:10.1016/j.msard.2024.106155
Physical and psychological aspects of multiple sclerosis: Revisiting the Multiple Sclerosis Impact Scale (MSIS-29).
Young, C. A., Rog, D. J., Sharrack, B., Tanasescu, R., Kalra, S., Chhetri, S. K., . . . Tennant, A. (2024). Physical and psychological aspects of multiple sclerosis: Revisiting the Multiple Sclerosis Impact Scale (MSIS-29).. Multiple sclerosis (Houndmills, Basingstoke, England), 13524585241288393. doi:10.1177/13524585241288393
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.
Blackstone, J., Williams, T., Nicholas, J. M., Bordea, E., De Angelis, F., Bianchi, A., . . . Chataway, J. (2024). Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.. BMJ open, 14(9), e086414. doi:10.1136/bmjopen-2024-086414
Stigma and health outcomes in multiple sclerosis: a systematic review.
Powell, B., Mills, R., Tennant, A., Young, C. A., & Langdon, D. (2024). Stigma and health outcomes in multiple sclerosis: a systematic review.. BMC neurology, 24(1), 346. doi:10.1186/s12883-024-03853-3
Rasch analysis of the modified Fatigue Severity Scale in neuromuscular disorders and comparison between sex, age and diagnoses.
Fulton, J. P. J., Holt, J. K. L., Mills, R. J., & Young, C. A. (2024). Rasch analysis of the modified Fatigue Severity Scale in neuromuscular disorders and comparison between sex, age and diagnoses.. Muscle & nerve, 70(3), 387-394. doi:10.1002/mus.28186
Rasch analysis of the Unidimensional Self-Efficacy Scale in Neuromuscular Disorders and comparison between sex, age, and diagnoses.
Fulton, J. P. J., Holt, J. K. L., Mills, R. J., & Young, C. A. (2024). Rasch analysis of the Unidimensional Self-Efficacy Scale in Neuromuscular Disorders and comparison between sex, age, and diagnoses.. Muscle & nerve, 70(2), 187-193. doi:10.1002/mus.28104
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.
Young, C. A., Chaouch, A., Mcdermott, C. J., Al-Chalabi, A., Chhetri, S. K., Talbot, K., . . . TONIC-ALS STUDY GROUP. (2024). Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.. Amyotrophic lateral sclerosis & frontotemporal degeneration, 1-11. doi:10.1080/21678421.2024.2322545
Prevalence, treatment and correlates of depression in multiple sclerosis.
Young, C. A., Langdon, D., Rog, D., Chhetri, S. K., Tanasescu, R., Kalra, S., . . . TONiC study group. (2024). Prevalence, treatment and correlates of depression in multiple sclerosis.. Multiple sclerosis and related disorders, 87, 105648. doi:10.1016/j.msard.2024.105648
Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis.
Young, C. A., Rog, D. J., Sharrack, B., Tanasescu, R., Kalra, S., Harrower, T., . . . Trajectories of Outcome in Neurological Conditions-MS Study Group. (2024). Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis.. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 45(5), 2181-2189. doi:10.1007/s10072-023-07155-3
Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change.
Young, C. A., Chaouch, A., Mcdermott, C. J., Al-Chalabi, A., Chhetri, S. K., Talbot, K., . . . Tennant, A. (2024). Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change.. Amyotrophic lateral sclerosis & frontotemporal degeneration, 1-10. doi:10.1080/21678421.2024.2322539
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
Brittain, G., Petrie, J., Duffy, K. E. M., Glover, R., Hullock, K., Papaioannou, D., . . . StarMS trial team. (2024). Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.. BMJ open, 14(2), e083582. doi:10.1136/bmjopen-2023-083582
Letter to the editor: Classification and management of sexual dysfunctions in multiple sclerosis patients: A review of current literature, <i>Campetella et al</i>.
Atayi, A. A., Khadr, R. N., Floyd, M. S., & Young, C. A. (2024). Letter to the editor: Classification and management of sexual dysfunctions in multiple sclerosis patients: A review of current literature, <i>Campetella et al</i>.. Urologia, 91(1), 237. doi:10.1177/03915603231199529
2023
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.
Lombardo, F. L., Spila Alegiani, S., Mayer, F., Cipriani, M., Lo Giudice, M., Ludolph, A. C., . . . TUDCA-ALS Study Group. (2023). A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.. Trials, 24(1), 792. doi:10.1186/s13063-023-07638-w
Multiple Sclerosis vision questionnaire (MSVQ-7): Reliability, validity, precision and discrimination.
Young, C. A., Rog, D. J., Tanasescu, R., Kalra, S., Langdon, D., Tennant, A., . . . Trajectories of Outcome in Neurological Conditions (MS) Study Group. (2023). Multiple Sclerosis vision questionnaire (MSVQ-7): Reliability, validity, precision and discrimination.. Multiple sclerosis and related disorders, 80, 105115. doi:10.1016/j.msard.2023.105115
The Association of Health Locus of Control with Clinical and Psychosocial Aspects of Living with Multiple Sclerosis
Rothman, I., Tennant, A., Mills, R. J., & Young, C. A. (2023). The Association of Health Locus of Control with Clinical and Psychosocial Aspects of Living with Multiple Sclerosis. JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS, 30(4), 821-835. doi:10.1007/s10880-023-09938-4
Measuring disability in multiple sclerosis: the WHODAS 2.0
Young, C. J., Rog, D., Sharrack, B., Constantinescu, C., Kalra, S., Harrower, T., . . . Mills, R. (2023). Measuring disability in multiple sclerosis: the WHODAS 2.0. QUALITY OF LIFE RESEARCH, 32(11), 3235-3246. doi:10.1007/s11136-023-03470-6
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trial
Williams, T., John, N., Calvi, A., Bianchi, A., De Angelis, F., Doshi, A., . . . Chataway, J. (2023). Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trial. EUROPEAN JOURNAL OF NEUROLOGY. doi:10.1111/ene.15924
Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study
Gould, R., Rawlinson, C. K., Thompson, B., Weeks, K., Gossage-Worrall, R., Cantrill, H. A., . . . McDermott, C. (2023). Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study. PILOT AND FEASIBILITY STUDIES, 9(1). doi:10.1186/s40814-023-01354-7
Healthier living with MS: The key role of self-efficacy and emotion regulation
Dehghan, M., Sharifi, P., Hasani, J., Young, C. A., & Langdon, D. (2023). Healthier living with MS: The key role of self-efficacy and emotion regulation. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 73. doi:10.1016/j.msard.2023.104608
Comparison Of King's Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts
Balendra, R., Jones, A. R., Al Khleifat, A., Chiwera, T., Wicks, P., Young, C. A., . . . Al-Chalabi, A. (2023). Comparison Of King's Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 24(1-2), 71-81. doi:10.1080/21678421.2022.2090847
Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12
Young, C. A., Ealing, J., McDermott, C. J., Williams, T. L., Al-Chalabi, A., Majeed, T., . . . Tennant, A. (2023). Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 24(1-2), 63-70. doi:10.1080/21678421.2022.2102926
Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months
Young, C. A., Ealing, J., McDermott, C. J., Williams, T. L., Al-Chalabi, A., Majeed, T., . . . Tennant, A. (2023). Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 24(1-2), 82-90. doi:10.1080/21678421.2022.2096410
2022
Measuring coping in multiple sclerosis: The Coping Index-MS
Young, C. A., Mills, R. J., Langdon, D., Rog, D. J., Sharrack, B., Kalra, S., . . . Tennant, A. (2022). Measuring coping in multiple sclerosis: The Coping Index-MS. MULTIPLE SCLEROSIS JOURNAL, 28(14), 2274-2284. doi:10.1177/13524585221114004
Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol.
Albanese, A., Ludolph, A. C., McDermott, C. J., Corcia, P., Van Damme, P., Van den Berg, L. H., . . . TUDCA-ALS Study Group. (2022). Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol.. Frontiers in neurology, 13, 1009113. doi:10.3389/fneur.2022.1009113
ASSOCIATION OF LOCUS OF CONTROL WITH CLINICAL AND PSYCHOSOCIAL ASPECTS OF LIVING WITH MULTIPLE SCLEROSIS
Rothman, I., Tennant, A., Mills, R., & Young, C. (2022). ASSOCIATION OF LOCUS OF CONTROL WITH CLINICAL AND PSYCHOSOCIAL ASPECTS OF LIVING WITH MULTIPLE SCLEROSIS. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 93. doi:10.1136/jnnp-2022-abn2.200
NATALIZUMAB TREATMENT SATISFACTION IN TONIC-MS STUDY: PRELIMINARY RESULTS FROM IVPARTICIPANTS ON INFUSION EXPERIENCE
James, B., Mills, R., Vonsy, J., Langdon, D., Ando, H., & Young, C. (2022). NATALIZUMAB TREATMENT SATISFACTION IN TONIC-MS STUDY: PRELIMINARY RESULTS FROM IVPARTICIPANTS ON INFUSION EXPERIENCE. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 93. doi:10.1136/jnnp-2022-abn2.202
Natalizumab treatment satisfaction in the TONiC-MS study: study design
James, B., Mills, R., Vonsy, J., Langdon, D., Ando, H., & Young, C. (2022). Natalizumab treatment satisfaction in the TONiC-MS study: study design. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 93. doi:10.1136/jnnp-2022-abn2.201
Fatigue and anxiety mediate the effect of dyspnea on quality of life in amyotrophic lateral sclerosis
Young, C., Ealing, J., McDermott, C., Williams, T., Al-Chalabi, A., Majeed, T., . . . Tennant, A. (2022). Fatigue and anxiety mediate the effect of dyspnea on quality of life in amyotrophic lateral sclerosis. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 23(5-6), 390-398. doi:10.1080/21678421.2021.1990343
Efficacy of Fluoxetine, Riluzole and Amiloride in treating neuropathic pain associated with secondary progressive multiple sclerosis. Pre-specified analysis of the MS-SMART double-blind randomised placebo-controlled trial
Foley, P., Parker, R. A., de Angelis, F., Connick, P., Chandran, S., Young, C., . . . Chataway, J. (2022). Efficacy of Fluoxetine, Riluzole and Amiloride in treating neuropathic pain associated with secondary progressive multiple sclerosis. Pre-specified analysis of the MS-SMART double-blind randomised placebo-controlled trial. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 63. doi:10.1016/j.msard.2022.103925
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)
Dobson, R., Craner, M., Ed Waddingham, E., Miller, A., Pindoria, J., Cavey, A., . . . Matthews, P. (2022). Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS). MULTIPLE SCLEROSIS AND RELATED DISORDERS, 63. doi:10.1016/j.msard.2022.103894
Understanding quality of life across different clinical subtypes of multiple sclerosis: a thematic analysis
Ando, H., Cousins, R., & Young, C. A. (2022). Understanding quality of life across different clinical subtypes of multiple sclerosis: a thematic analysis. QUALITY OF LIFE RESEARCH, 31(7), 2035-2046. doi:10.1007/s11136-021-03041-7
What would improve MS clinic services for cognition? - A stakeholder panel and survey exploration
Langdon, D., Coutts, M., McGuigan, C., Morrow, B., Peryer, G., & Young, C. A. (2022). What would improve MS clinic services for cognition? - A stakeholder panel and survey exploration. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 63. doi:10.1016/j.msard.2022.103930
Flexibility to manage and enhance quality of life among people with motor neurone disease
Ando, H., Cousins, R., & Young, C. A. (2022). Flexibility to manage and enhance quality of life among people with motor neurone disease. DISABILITY AND REHABILITATION, 44(12), 2752-2762. doi:10.1080/09638288.2020.1846797
Diagnosing ALS: the Gold Coast criteria and the role of EMG.
Turner, M. R., & UK MND Clinical Studies Group. (2022). Diagnosing ALS: the Gold Coast criteria and the role of EMG.. Practical neurology, 22(3), 176-178. doi:10.1136/practneurol-2021-003256
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis
James, E., Ellis, C., Brassington, R., Sathasivam, S., & Young, C. A. (2022). Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD006981.pub3
The four self-efficacy trajectories among people with multiple sclerosis: Clinical associations and implications
Young, C. A., Mills, R., Langdon, D., Sharrack, B., Majeed, T., Kalra, S., . . . Tennant, A. (2022). The four self-efficacy trajectories among people with multiple sclerosis: Clinical associations and implications. JOURNAL OF THE NEUROLOGICAL SCIENCES, 436. doi:10.1016/j.jns.2022.120188
Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project
Celani, M. G., Nonino, F., Mahan, K., Orso, M., Ridley, B., Baldin, E., . . . Filippini, G. (2022). Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 60. doi:10.1016/j.msard.2022.103688
Androgen-modulating agents for spinal bulbar muscular atrophy/Kennedy's disease
Hoo, F. K., Hasan Sumon, M. S., Basri, H., Wan Sulaiman, W. A., Stanslas, J., Zaman Hashim, H., & Young, C. A. (n.d.). Androgen-modulating agents for spinal bulbar muscular atrophy/Kennedy's disease. Cochrane Database of Systematic Reviews, 2022(1). doi:10.1002/14651858.cd012000.pub2
Medical therapies for amyotrophic lateral sclerosis-related respiratory decline: an appraisal of needs, opportunities and obstacles
Young, C., Pinto, S., Grosskreutz, J., Hardiman, O., Clawson, L. L., Cudkowicz, M. E., & Andrews, J. A. (2022). Medical therapies for amyotrophic lateral sclerosis-related respiratory decline: an appraisal of needs, opportunities and obstacles. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 23(1-2), 66-75. doi:10.1080/21678421.2021.1920981
Natalizumab treatment satisfaction in the TONiC-MS study: preliminary resultssupport from NIHR, MNDA, Walton Neuroscience Charity, Biogen, Novartis, Roche, Teva
Mills, R., James, B., Vonsy, J., Langdon, D., Ando, H., & Young, C. (2022). Natalizumab treatment satisfaction in the TONiC-MS study: preliminary resultssupport from NIHR, MNDA, Walton Neuroscience Charity, Biogen, Novartis, Roche, Teva. In MULTIPLE SCLEROSIS JOURNAL Vol. 28 (pp. 360). Retrieved from https://www.webofscience.com/
2021
A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyond
Masoli, J. A. H., Down, K., Nestor, G., Hudson, S., O'Brien, J. T., Williamson, J. D., . . . Carroll, C. (2021). A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyond. TRIALS, 22(1). doi:10.1186/s13063-021-05880-8
OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis
Dobson, R., Craner, M., Waddingham, E., Miller, A., Cavey, A., Webb, S., . . . Matthews, P. M. (2021). OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis. BMJ OPEN, 11(11). doi:10.1136/bmjopen-2021-050176
Minocycline for amyotrophic lateral sclerosis or motor neuron disease
Sathasivam, S., Addison-Jones, R., Miller, R. G., Moore, D. H., & Young, C. A. (n.d.). Minocycline for amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database of Systematic Reviews, 2021(11). doi:10.1002/14651858.cd006840.pub2
Letter to the editor re: the effect of pelvic floor exercise program on incontinence and sexual dysfunction in multiple sclerosis patients <i>Altunan</i> et al., IJUN, (2021) 53:1059
McNicholas, D. P., Floyd, M. S. J., Mann, K. R., Khadr, R. N., & Young, C. A. (2021). Letter to the editor re: the effect of pelvic floor exercise program on incontinence and sexual dysfunction in multiple sclerosis patients <i>Altunan</i> et al., IJUN, (2021) 53:1059. INTERNATIONAL UROLOGY AND NEPHROLOGY, 53(11), 2297-2298. doi:10.1007/s11255-021-02958-9
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study) : a randomised, double-blind, placebo-controlled phase 3 trial
Cudkowicz, M., Genge, A., Maragakis, N., Petri, S., van den Berg, L., Aho, V. V., . . . Al-Chalabi, A. (2021). Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study) : a randomised, double-blind, placebo-controlled phase 3 trial. LANCET NEUROLOGY, 20(10), 821-831. doi:10.1016/S1474-4422(21)00242-8
Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy
Young, C. A., Mills, R., Rog, D., Sharrack, B., Majeed, T., Constantinescu, C. S., . . . Tennant, A. (2021). Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy. JOURNAL OF THE NEUROLOGICAL SCIENCES, 426. doi:10.1016/j.jns.2021.117437
A Report From The NIHR UK Working Group On Remote Trial Delivery For The COVID-19 Pandemic and Beyond
Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale.
Young, C. A., McDermott, C. J., Williams, T. L., Ealing, J., Majeed, T., Al-Chalabi, A., . . . TONiC study group. (2021). Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale.. Journal of the neurological sciences, 421, 117285. doi:10.1016/j.jns.2020.117285
2020
Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis
Saxon, J. A., Thompson, J. C., Harris, J. M., Richardson, A. M., Langheinrich, T., Rollinson, S., . . . Snowden, J. S. (2020). Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 91(12), 1304-1311. doi:10.1136/jnnp-2020-323969
Letter to the editor re: Worsening disability status in multiple sclerosis predicts urologic complications. Int Urol Nephrol. May; 52(5):859-863. doi: 10.1007/s11255-020-02381-6. Epub 2020 Jan 25 by Abello et al
Floyd, M. S. J., Khadr, R. N., & Young, C. A. (2020). Letter to the editor re: Worsening disability status in multiple sclerosis predicts urologic complications. Int Urol Nephrol. May; 52(5):859-863. doi: 10.1007/s11255-020-02381-6. Epub 2020 Jan 25 by Abello et al. INTERNATIONAL UROLOGY AND NEPHROLOGY, 52(12), 2307-2308. doi:10.1007/s11255-020-02551-6
Is NIPA1-associated hereditary spastic paraplegia always 'pure'? Further evidence of motor neurone disease and epilepsy as rare manifestations
Tanti, M., Cairns, D., Mirza, N., McCann, E., & Young, C. (2020). Is NIPA1-associated hereditary spastic paraplegia always 'pure'? Further evidence of motor neurone disease and epilepsy as rare manifestations. NEUROGENETICS, 21(4), 305-308. doi:10.1007/s10048-020-00619-0
The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia
Saxon, J. A., Thompson, J. C., Harris, J. M., Ealing, J., Hamdalla, H., Chaouch, A., . . . Snowden, J. S. (2020). The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. doi:10.1080/21678421.2020.1797090
Effect of Short-term Integrated Palliative Care on Patient-Reported Outcomes Among Patients Severely Affected With Long-term Neurological Conditions A Randomized Clinical Trial
Gao, W., Wilson, R., Hepgul, N., Yi, D., Evans, C., Bajwah, S., . . . Higginson, I. J. (2020). Effect of Short-term Integrated Palliative Care on Patient-Reported Outcomes Among Patients Severely Affected With Long-term Neurological Conditions A Randomized Clinical Trial. JAMA NETWORK OPEN, 3(8). doi:10.1001/jamanetworkopen.2020.15061
The WHOQOL-BREF: a modern psychometric evaluation of its internal construct validity in people with multiple sclerosis
Pomeroy, I. M., Tennant, A., Mills, R. J., & Young, C. A. (2020). The WHOQOL-BREF: a modern psychometric evaluation of its internal construct validity in people with multiple sclerosis. QUALITY OF LIFE RESEARCH, 29(7), 1961-1972. doi:10.1007/s11136-020-02463-z
Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF
Young, C. A., Mills, R., Al-Chalabi, A., Burke, G., Chandran, S., Dick, D. J., . . . TONiC study group. (n.d.). Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF. Amyotrophic lateral sclerosis & frontotemporal degeneration. doi:10.1080/21678421.2020.1752244
Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019)
Luenemann, J. D., Diaz-Diaz, J., Stankoff, B., Young, C., Siva, A., Miller, A., . . . Oreja-Guevara, C. (2020). Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019). MULTIPLE SCLEROSIS JOURNAL, 26(7), 859-868. doi:10.1177/1352458520918377
Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis
James, E., Young, C. A., Gibbons, E. L., Shueb, A., & Tur, C. (n.d.). Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013599
Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature
Edge, R., Mills, R., Tennant, A., Diggle, P. J., Young, C. A., Al-Chalabi, A., . . . Harrower, T. (2020). Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature. JOURNAL OF NEUROLOGY, 267(3), 607-615. doi:10.1007/s00415-019-09615-3
Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature (vol 267, pg 607, 2020)
Edge, R., Mills, R., Tennant, A., Diggle, P. J., Young, C. A., Al-Chalabi, A., . . . Harrower, T. (2020). Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature (vol 267, pg 607, 2020). JOURNAL OF NEUROLOGY, 267(3), 616-617. doi:10.1007/s00415-020-09700-y
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
Chataway, J., De Angelis, F., Connick, P., Parker, R. A., Plantone, D., Doshi, A., . . . McLean, B. (2020). Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial. LANCET NEUROLOGY, 19(3), 214-225. doi:10.1016/S1474-4422(19)30485-5
Cognitive rehabilitation for attention and memory in people with multiple sclerosis: a randomized controlled trial (CRAMMS)
Lincoln, N. B., Bradshaw, L. E., Constantinescu, C. S., Day, F., Drummond, A. E. R., Fitzsimmons, D., . . . das Nair, R. (2020). Cognitive rehabilitation for attention and memory in people with multiple sclerosis: a randomized controlled trial (CRAMMS). CLINICAL REHABILITATION, 34(2), 229-241. doi:10.1177/0269215519890378
Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT
Lincoln, N. B., Bradshaw, L. E., Constantinescu, C. S., Day, F., Drummond, A. E. R., Fitzsimmons, D., . . . Rose, A. (2020). Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT. HEALTH TECHNOLOGY ASSESSMENT, 24(4), 1-+. doi:10.3310/hta24040
Immediate versus delayed short-term integrated palliative care for advanced long-term neurological conditions: the OPTCARE Neuro RCT
Hepgul, N., Wilson, R., Yi, D., Evans, C., Bajwah, S., Crosby, V., . . . Gao, W. (2020). Immediate versus delayed short-term integrated palliative care for advanced long-term neurological conditions: the OPTCARE Neuro RCT.
Is multiple sclerosis a length-dependent central axonopathy ? Some empiric data from the tonic study
Mills, R., Schluter, D., Diggle, P., Young, C., & Tennant, A. (2020). Is multiple sclerosis a length-dependent central axonopathy ? Some empiric data from the tonic study. In MULTIPLE SCLEROSIS JOURNAL Vol. 26 (pp. 535). Retrieved from https://www.webofscience.com/
2019
DEVELOPMENT OF CLINICAL AND PATIENT-REPORTED QUALITY METRICS FOR MULTIPLE SCLEROSIS: A UK PILOT STUDY REPORT
Giovannoni, G., White, S., Mistry, N., Calhoun, S., Young, C., Coutts, M., . . . Hobart, J. (2019). DEVELOPMENT OF CLINICAL AND PATIENT-REPORTED QUALITY METRICS FOR MULTIPLE SCLEROSIS: A UK PILOT STUDY REPORT. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 90 (pp. E54). doi:10.1136/jnnp-2019-ABN-2.150
UPDATED SAFETY ANALYSIS OF OCRELIZUMAB IN MULTIPLE SCLEROSIS
Young, C., Hauser, S., Kappos, L., Montalban, X., Hughes, R., Koendgen, H., . . . Wolinsky, J. (2019). UPDATED SAFETY ANALYSIS OF OCRELIZUMAB IN MULTIPLE SCLEROSIS. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 90 (pp. E56). doi:10.1136/jnnp-2019-ABN-2.157
Health Utilities and Costs for Motor Neurone Disease
Moore, A., Young, C. A., & Hughes, D. A. (2019). Health Utilities and Costs for Motor Neurone Disease. VALUE IN HEALTH, 22(11), 1257-1265. doi:10.1016/j.jval.2019.05.011
A phase III trial of <i>tirasemtiv</i> as a potential treatment for amyotrophic lateral sclerosis
Shefner, J. M., Cudkowicz, M. E., Hardiman, O., Cockroft, B. M., Lee, J. H., Malik, F. I., . . . Barkhaus, P. (2019). A phase III trial of <i>tirasemtiv</i> as a potential treatment for amyotrophic lateral sclerosis. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 20(7-8), 584-594. doi:10.1080/21678421.2019.1612922
Communicating psychosocial well-being in motor neurone disease to staff: results from a World Cafe approach
Giebel, C., Medley, G., Smith, S., Thornton, M., Furlong, M., Ennis, M., & Young, C. (2019). Communicating psychosocial well-being in motor neurone disease to staff: results from a World Cafe approach. QUALITY OF LIFE RESEARCH, 28(9), 2579-2584. doi:10.1007/s11136-019-02193-x
Experience of telehealth in people with motor neurone disease using noninvasive ventilation.
Ando, H., Ashcroft-Kelso, H., Halhead, R., Chakrabarti, B., Young, C. A., Cousins, R., & Angus, R. M. (2019). Experience of telehealth in people with motor neurone disease using noninvasive ventilation.. Disability and rehabilitation. Assistive technology, 1-7. doi:10.1080/17483107.2019.1659864
Use of coping strategies in MND/ALS: Association with demographic and disease-related characteristics
Schluter, D. K., Holland, D. P., Mills, R. J., McDermott, C. J., Williams, T. L., & Young, C. A. (2019). Use of coping strategies in MND/ALS: Association with demographic and disease-related characteristics. ACTA NEUROLOGICA SCANDINAVICA, 140(2), 131-139. doi:10.1111/ane.13113
Test equating sleep scales: applying the Leunbach's model
Adroher, N. D., Kreiner, S., Young, C., Mills, R., & Tennant, A. (2019). Test equating sleep scales: applying the Leunbach's model. BMC MEDICAL RESEARCH METHODOLOGY, 19. doi:10.1186/s12874-019-0768-y
Incorporating self-reported questions for telemonitoring to optimize care of patients with MND on noninvasive ventilation (MND OptNIVent)
Ando, H., Ashcroft-Kelso, H., Halhead, R., Young, C. A., Chakrabarti, B., Levene, P., . . . Angus, R. M. (2019). Incorporating self-reported questions for telemonitoring to optimize care of patients with MND on noninvasive ventilation (MND OptNIVent). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(5-6), 336-347. doi:10.1080/21678421.2019.1587630
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease
Young, C. A., Ealing, J., Mcdermott, C., Williams, T., Al-chalabi, A., Majeed, T., . . . Tennant, A. (2019). The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. doi:10.1080/21678421.2019.1615951
Exploring and Addressing 'Concerns' for Significant Others to Extend the Understanding of Quality of Life With Amyotrophic Lateral Sclerosis: A Qualitative Study
Ando, H., Cousins, R., & Young, C. A. (2019). Exploring and Addressing 'Concerns' for Significant Others to Extend the Understanding of Quality of Life With Amyotrophic Lateral Sclerosis: A Qualitative Study. JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 11. doi:10.1177/1179573519859360
Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics
Holland, D. P., Schluter, D. K., Young, C. A., Mills, R. J., Rog, D. J., Ford, H. L., & Orchard, K. (2019). Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 27, 214-222. doi:10.1016/j.msard.2018.10.016
2018
Risk factors for social withdrawal in amyotrophic lateral sclerosis/motor neurone disease
Schluter, D. K., Tennant, A., Mills, R., Diggle, P. J., Young, C. A., & Grp, T. S. (2018). Risk factors for social withdrawal in amyotrophic lateral sclerosis/motor neurone disease. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 19(7-8), 591-598. doi:10.1080/21678421.2018.1508477
Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease
Moore, A., Young, C. A., & Hughes, D. A. (2018). Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease. VALUE IN HEALTH, 21(11), 1322-1329. doi:10.1016/j.jval.2018.05.005
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
Connick, P., De Angelis, F., Parker, R. A., Plantone, D., Doshi, A., John, N., . . . UK Multiple Sclerosis Society Clinical Trials Network. (2018). Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.. BMJ open, 8(8), e021944. doi:10.1136/bmjopen-2018-021944
Development and validation of Spasticity IndexAmyotrophic Lateral Sclerosis
Milinis, K., Tennant, A., Mills, R. J., Al-Chalabi, A., Burke, G., Dick, D. J., . . . Young, C. A. (2018). Development and validation of Spasticity IndexAmyotrophic Lateral Sclerosis. ACTA NEUROLOGICA SCANDINAVICA, 138(1), 47-54. doi:10.1111/ane.12910
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Kapoor, R., Ho, P. -R., Campbell, N., Chang, I., Deykin, A., Forrestal, F., . . . Steiner, D. (2018). Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. LANCET NEUROLOGY, 17(5), 405-415. doi:10.1016/S1474-4422(18)30069-3
Quality of life for post-polio syndrome: a patient derived, Rasch standard scale
Young, C. A., Quincey, A. -M. C., Wong, S. M., & Tennant, A. (n.d.). Quality of life for post-polio syndrome: a patient derived, Rasch standard scale. DISABILITY AND REHABILITATION, 40(5), 597-602. doi:10.1080/09638288.2016.1260650
Measuring Physical and Cognitive Fatigue in People With Post-Polio Syndrome: Development of the Neurological Fatigue Index for Post-Polio Syndrome (NFI-PP)
Young, C. A., Wong, S. M., Quincey, A. -M. C., & Tennant, A. (2018). Measuring Physical and Cognitive Fatigue in People With Post-Polio Syndrome: Development of the Neurological Fatigue Index for Post-Polio Syndrome (NFI-PP). PM&R, 10(2), 129-136. doi:10.1016/j.pmrj.2017.06.014
Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease
Gibbons, C., Pagnini, F., Friede, T., & Young, C. A. (2018). Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD011005.pub2
Coping in multiple sclerosis: qualitative analysis of themes
Young, C. A., Ando, H., & Cousins, R. (2018). Coping in multiple sclerosis: qualitative analysis of themes. In MULTIPLE SCLEROSIS JOURNAL Vol. 24 (pp. 796). Retrieved from https://www.webofscience.com/
Hope in multiple sclerosis: qualitative analysis of concepts and domains
Young, C. A., Ando, H., & Cousins, R. (2018). Hope in multiple sclerosis: qualitative analysis of concepts and domains. In MULTIPLE SCLEROSIS JOURNAL Vol. 24 (pp. 804-805). Retrieved from https://www.webofscience.com/
The World Health Organization Disability Assessment Scale in the measurement of activity and participation in multiple sclerosis
James, E., Tennant, A., Mills, R., Miele, G., & Young, C. A. (2018). The World Health Organization Disability Assessment Scale in the measurement of activity and participation in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 24 (pp. 343-344). Retrieved from https://www.webofscience.com/
The bio-psycho-social associations of smoking in multiple sclerosis
Mills, R., & Young, C. (2018). The bio-psycho-social associations of smoking in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 24 (pp. 194-195). Retrieved from https://www.webofscience.com/
2017
DEFINING THE DOMAINS OF A COMPOSITE ASSESSMENT TOOL FOR MS
Young, C., Chandran, S., Molyneux, P., Overell, J., Palace, J., Pettit, L. J., . . . Williams, A. (2017). DEFINING THE DOMAINS OF A COMPOSITE ASSESSMENT TOOL FOR MS. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 88 (pp. A51). doi:10.1136/jnnp-2017-ABN.175
DEVELOPMENT AND VALIDATION OF SPASTICITY INDEX - AMYOTROPHIC LATERAL SCLEROSIS (SI-ALS)
Milinis, K., Tenant, A., & Young, C. (2017). DEVELOPMENT AND VALIDATION OF SPASTICITY INDEX - AMYOTROPHIC LATERAL SCLEROSIS (SI-ALS). In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 88 (pp. A7). doi:10.1136/jnnp-2017-ABN.21
HEREDITARY SPASTIC PARAPLEGIA, EPILEPSY AND MOTOR NEURONE DISEASE IN A FAMILY WITH NIPA1 MUTATION
Tanti, M., Mirza, N., & Young, C. (2017). HEREDITARY SPASTIC PARAPLEGIA, EPILEPSY AND MOTOR NEURONE DISEASE IN A FAMILY WITH NIPA1 MUTATION. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 88 (pp. A61). doi:10.1136/jnnp-2017-ABN.209
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials
van Eijk, R. P. A., Jones, A. R., Sproviero, W., Shatunov, A., Shaw, P. J., Leigh, P. N., . . . Grp, U. K. M. N. D. -L. I. C. A. L. S. L. I. T. A. L. S. S. (2017). Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials. NEUROLOGY, 89(18), 1915-1922. doi:10.1212/WNL.0000000000004606
Sexual functioning in multiple sclerosis: Relationships with depression, fatigue and physical function
Young, C. A., Tennant, A., & Grp, T. S. (2017). Sexual functioning in multiple sclerosis: Relationships with depression, fatigue and physical function. MULTIPLE SCLEROSIS JOURNAL, 23(9), 1268-1275. doi:10.1177/1352458516675749
Inducing an availability heuristic on the Wason selection task overrides thematching bias
Taylor, J. P., Ashworth, S. J., Petrovich, S., & Young, C. A. (2017). Inducing an availability heuristic on the Wason selection task overrides thematching bias. JOURNAL OF COGNITIVE PSYCHOLOGY, 29(4), 508-519. doi:10.1080/20445911.2017.1281282
Comparison of the King's and MiToS staging systems for ALS.
Fang, T., Al Khleifat, A., Stahl, D. R., Lazo La Torre, C., Murphy, C., Uk-Mnd LicalS., . . . Al-Chalabi, A. (2017). Comparison of the King's and MiToS staging systems for ALS.. Amyotrophic lateral sclerosis & frontotemporal degeneration, 18(3-4), 227-232. doi:10.1080/21678421.2016.1265565
Economic Studies in Motor Neurone Disease: A Systematic Methodological Review
Moore, A., Young, C. A., & Hughes, D. A. (2017). Economic Studies in Motor Neurone Disease: A Systematic Methodological Review. PHARMACOECONOMICS, 35(4), 397-413. doi:10.1007/s40273-016-0478-9
Rasch analysis of SF-Qualiveen in multiple sclerosis
Milinis, K., Tennant, A., & Young, C. A. (2017). Rasch analysis of SF-Qualiveen in multiple sclerosis. NEUROUROLOGY AND URODYNAMICS, 36(4), 1161-1166. doi:10.1002/nau.23081
Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease
Ng, L., Khan, F., Young, C. A., & Galea, M. (2017). Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD011776.pub2
A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis
Mcgeachan, A. J., Hobson, E. V., Al-Chalabi, A., Stephenson, J., Chandran, S., Crawley, F., . . . Mcdermott, C. J. (2017). A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 18(1-2), 1-9. doi:10.1080/21678421.2016.1221433
Factors driving social withdrawal across multiple sclerosis disease types
Mills, R. J., Caldu, R., & Young, C. A. (2017). Factors driving social withdrawal across multiple sclerosis disease types. In MULTIPLE SCLEROSIS JOURNAL Vol. 23 (pp. 143). Retrieved from https://www.webofscience.com/
Is the EDSS a proxy for non-motor disability across multiple sclerosis disease types?
Mills, R. J., & Young, C. A. (2017). Is the EDSS a proxy for non-motor disability across multiple sclerosis disease types?. In MULTIPLE SCLEROSIS JOURNAL Vol. 23 (pp. 476). Retrieved from https://www.webofscience.com/
2016
QUALITATIVE ASSESSMENT OF THE EXPERIENCE OF TELEMONITORING IN VENTILATED PATIENTS WITH MOTOR NEURONE DISEASE
Ashcroft, H., Ando, H., Halhead, R., Chakrabarti, B., Young, C. A., Cousins, R., & Angus, R. M. (2016). QUALITATIVE ASSESSMENT OF THE EXPERIENCE OF TELEMONITORING IN VENTILATED PATIENTS WITH MOTOR NEURONE DISEASE. In THORAX Vol. 71 (pp. A34). doi:10.1136/thoraxjnl-2016-209333.63
USAGE AND EQUITABILITY OF MULTIPLE SCLEROSIS DMT IN ENGLAND
Mills, R., & Young, C. (2016). USAGE AND EQUITABILITY OF MULTIPLE SCLEROSIS DMT IN ENGLAND. In JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Vol. 87. doi:10.1136/jnnp-2016-315106.147
Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions
Milinis, K., & Young, C. A. (2016). Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions. DISABILITY AND REHABILITATION, 38(15), 1431-1441. doi:10.3109/09638288.2015.1106592
DiPALS: Diaphragm Pacing in patients with Amyotrophic Lateral Sclerosis - a randomised controlled trial
McDermott, C. J., Bradburn, M. J., Maguire, C., Cooper, C. L., Baird, W. O., Baxter, S. K., . . . Shaw, P. J. (2016). DiPALS: Diaphragm Pacing in patients with Amyotrophic Lateral Sclerosis - a randomised controlled trial. HEALTH TECHNOLOGY ASSESSMENT, 20(45), 1-+. doi:10.3310/hta20450
How integrated are neurology and palliative care services? Results of a multicentre mapping exercise
van Vliet, L. M., Gao, W., DiFrancesco, D., Crosby, V., Wilcock, A., Byrne, A., . . . Neuro, O. P. T. C. A. R. E. (2016). How integrated are neurology and palliative care services? Results of a multicentre mapping exercise. BMC NEUROLOGY, 16. doi:10.1186/s12883-016-0583-6
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis
Warrender-Sparkes, M., Spelman, T., Izquierdo, G., Trojano, M., Lugaresi, A., Grand'Maison, F., . . . Jokubaitis, V. (2016). The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL, 22(4), 520-532. doi:10.1177/1352458515594041
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group
McGuigan, C., Craner, M., Guadagno, J., Kapoor, R., Mazibrada, G., Molyneux, P., . . . Young, C. A. (2016). Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 87(2), 117-125. doi:10.1136/jnnp-2015-311100
Comparative health status and quality of life between Primary and Secondary Progressive Multiple Sclerosis
Young, C. A., Mills, R. J., & Tennant, A. (2016). Comparative health status and quality of life between Primary and Secondary Progressive Multiple Sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 58). Retrieved from https://www.webofscience.com/
Comparative health status and quality of life between Relapsing Remitting and Progressive Multiple Sclerosis
Young, C. A., Mills, R. J., & Tennant, A. (2016). Comparative health status and quality of life between Relapsing Remitting and Progressive Multiple Sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 29). Retrieved from https://www.webofscience.com/
Distinct patterns of fatigue and sleep dysfunction by MS phenotype and disability level
Mills, R. J., Tennant, A., & Young, C. A. (2016). Distinct patterns of fatigue and sleep dysfunction by MS phenotype and disability level. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 439). Retrieved from https://www.webofscience.com/
Effect of aspirin on flushing in relapsing-remitting multiple sclerosis patients receiving delayed-release dimethyl fumarate
Rog, D., Cader, S., Harrower, T., McGuigan, C., Young, C., Potts, J., & Hanna, J. (2016). Effect of aspirin on flushing in relapsing-remitting multiple sclerosis patients receiving delayed-release dimethyl fumarate. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 656-657). Retrieved from https://www.webofscience.com/
Identification of coping strategies in Multiple Sclerosis
James, E., Mills, R. J., Tennant, A., & Young, C. A. (2016). Identification of coping strategies in Multiple Sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 432). Retrieved from https://www.webofscience.com/
Internal construct validity and reliability of the neuropathic pain scale in multiple sclerosis: a rasch analysis
Young, C. A., Mills, R. J., & Tennant, A. (2016). Internal construct validity and reliability of the neuropathic pain scale in multiple sclerosis: a rasch analysis. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 139-140). Retrieved from https://www.webofscience.com/
Neuropathic pain in multiple sclerosis
Young, C. A., Mills, R. J., & Tennant, A. (2016). Neuropathic pain in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 130). Retrieved from https://www.webofscience.com/
Psychological distress in Multiple Sclerosis and its correlation with coping strategies
James, E., Mills, R. J., Tennant, A., & Young, C. A. (2016). Psychological distress in Multiple Sclerosis and its correlation with coping strategies. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 432-433). Retrieved from https://www.webofscience.com/
Should we 'watch and wait'? The effects of disease modifying treatment on MS impact and quality of life
Mills, R. J., Tennant, A., & Young, C. A. (2016). Should we 'watch and wait'? The effects of disease modifying treatment on MS impact and quality of life. In MULTIPLE SCLEROSIS JOURNAL Vol. 22 (pp. 812). Retrieved from https://www.webofscience.com/
Spasticity in multiple sclerosis: Associations with impairments and overall quality of life
Milinis, K., Tennant, A., & Young, C. A. (2016). Spasticity in multiple sclerosis: Associations with impairments and overall quality of life. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 5, 34-39. doi:10.1016/j.msard.2015.10.007
Spasticity in multiple sclerosis: Associations with impairments and overall quality of life
Milinis, K., Tennant, A., & Young, C. A. (2016). Spasticity in multiple sclerosis: Associations with impairments and overall quality of life. Multiple Sclerosis and Related Disorders, 5, 34-39. doi:10.1016/j.msard.2015.10.007
The Neurological Sleep Index: A suite of new sleep scales for multiple sclerosis.
Mills, R. J., Tennant, A., & Young, C. A. (2016). The Neurological Sleep Index: A suite of new sleep scales for multiple sclerosis.. Multiple sclerosis journal - experimental, translational and clinical, 2, 2055217316642263. doi:10.1177/2055217316642263
2015
Androgen-modulating agents for spinal bulbar muscular atrophy/Kennedy's disease
Hoo, F. K., Hasan Sumon, M. S., Basri, H., Wan Sulaiman, W. A., Stanslas, J., Zaman Hashim, H., & Young, C. A. (n.d.). Androgen-modulating agents for spinal bulbar muscular atrophy/Kennedy's disease. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd012000
Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis
van der Kleij, L. A., Jones, A. R., Steen, I. N., Young, C. A., Shaw, P. J., Shaw, C. E., . . . Al-Chalabi, A. (2015). Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 16(7-8), 442-447. doi:10.3109/21678421.2015.1051987
Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder
Mutch, K., Zhao, S., Hamid, S., Methley, A., Elsone, L., Singh, G., . . . Jacob, A. (2015). Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 4(6), 614-618. doi:10.1016/j.msard.2015.07.015
Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial
McDermott, C. J., Shaw, P. J., Cooper, C. L., Dixon, S., Baird, W. O., Bradburn, M. J., . . . Hanemann, C. O. (2015). Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial. LANCET NEUROLOGY, 14(9), 883-892. doi:10.1016/S1474-4422(15)00152-0
Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study
McDermott, C. J., Shaw, P. J., Stavroulakis, T., Walters, S. J., Al-Chalabi, A., Chandran, S., . . . Young, C. (2015). Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. LANCET NEUROLOGY, 14(7), 702-709. doi:10.1016/S1474-4422(15)00104-0
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report
Rathnasabapathi, D., Elsone, L., Krishnan, A., Young, C., Larner, A., & Jacob, A. (2015). Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report. JOURNAL OF SPINAL CORD MEDICINE, 38(4), 545-549. doi:10.1179/2045772314Y.0000000283
Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease
Ng, L., Khan, F., & Young, C. A. (n.d.). Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease. doi:10.1002/14651858.cd011776
Anticholinergics for urinary symptoms in multiple sclerosis (Withdrawn Paper. 2015, Art. no. CD004193)
Nicholas, R. S., Friede, T., Hollis, S., & Young, C. A. (2015). Anticholinergics for urinary symptoms in multiple sclerosis (Withdrawn Paper. 2015, Art. no. CD004193). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD004193.pub3
Why don't they accept non-invasive ventilation?: Insight into the interpersonal perspectives of patients with motor neurone disease
Ando, H., Williams, C., Angus, R. M., Thornton, E. W., Chakrabarti, B., Cousins, R., . . . Young, C. A. (2015). Why don't they accept non-invasive ventilation?: Insight into the interpersonal perspectives of patients with motor neurone disease. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 20(2), 341-359. doi:10.1111/bjhp.12104
An assessment of felt-stigma in multiple sclerosis
Mills, R. J., Eva, Z., Tennant, A., & Young, C. A. (2015). An assessment of felt-stigma in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 619-620). Retrieved from https://www.webofscience.com/
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.
Scolding, N., Barnes, D., Cader, S., Chataway, J., Chaudhuri, A., Coles, A., . . . Zajicek, J. (2015). Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.. Practical neurology, 15(4), 273-279. doi:10.1136/practneurol-2015-001139
Coping strategies used by people with multiple sclerosis
Holland, D., Mills, R. M., Tennant, A., & Young, C. A. (2015). Coping strategies used by people with multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 622-623). Retrieved from https://www.webofscience.com/
Fatigue and quality of life in multiple sclerosis: the mediating effect of activity limitation and the moderating effect of gender and disease type
Young, C. A., & Tennant, A. (2015). Fatigue and quality of life in multiple sclerosis: the mediating effect of activity limitation and the moderating effect of gender and disease type. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 340). Retrieved from https://www.webofscience.com/
Neurological Coping Index-MS: a short positive coping scale for multiple sclerosis
Mills, R. J., Tennant, A., & Young, C. A. (2015). Neurological Coping Index-MS: a short positive coping scale for multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 620-621). Retrieved from https://www.webofscience.com/
Rasch analysis of the Herth Hope Index in multiple sclerosis
Mills, R. J., Tennant, A., & Young, C. A. (2015). Rasch analysis of the Herth Hope Index in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 620). Retrieved from https://www.webofscience.com/
Sexual functioning in multiple sclerosis
Young, C. A., & Tennant, A. (2015). Sexual functioning in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 117). Retrieved from https://www.webofscience.com/
The WHOQOL-Bref in MS: impact and satisfaction?
Pomeroy, I., Tennant, A., & Young, C. A. (2015). The WHOQOL-Bref in MS: impact and satisfaction?. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 125). Retrieved from https://www.webofscience.com/
The impact of urinary dysfunction in multiple sclerosis: rasch analysis of the SF-Qualiveen
Milinis, K., Mills, R., Tennant, A., & Young, C. (2015). The impact of urinary dysfunction in multiple sclerosis: rasch analysis of the SF-Qualiveen. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 340-341). Retrieved from https://www.webofscience.com/
The role of positive coping and hopefulness in predicting quality of life in multiple sclerosis
Young, C. A., & Tennant, A. (2015). The role of positive coping and hopefulness in predicting quality of life in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 339). Retrieved from https://www.webofscience.com/
Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
Balendra, R., Jones, A., Jivraj, N., Steen, I. N., Young, C. A., Shaw, P. J., . . . Al-Chalabi, A. (2015). Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 86(1), 45-49. doi:10.1136/jnnp-2013-306865
Worry and self-esteem in multiple sclerosis
Zitnik, E., Mills, R. M., Tennant, A., & Young, C. A. (2015). Worry and self-esteem in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 21 (pp. 623-624). Retrieved from https://www.webofscience.com/
2014
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
Filippi, M., Rocca, M. A., Pagani, E., De Stefano, N., Jeffery, D., Kappos, L., . . . ALLEGRO Study Group. (2014). Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.. Journal of neurology, neurosurgery, and psychiatry, 85(8), 851-858. doi:10.1136/jnnp-2013-306132
Treatment for fatigue in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND)
Young, C. A., Gibbons, C., Pagnini, F., & Friede, T. (n.d.). Treatment for fatigue in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011005
Achieving Saturation in Thematic Analysis: Development and Refinement of a Codebook
Ando, H., Cousins, R., & Young, C. (2014). Achieving Saturation in Thematic Analysis: Development and Refinement of a Codebook. Comprehensive Psychology, 3, 03.CP.3.4. doi:10.2466/03.cp.3.4
Development of the neurological coping index for multiple sclerosis (NCI-MS)
Young, C. A., & Tennant, A. (2014). Development of the neurological coping index for multiple sclerosis (NCI-MS). In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 388-389). Retrieved from https://www.webofscience.com/
Development of the neurological hope index for multiple sclerosis (NHI-MS)
Young, C. A., & Tennant, A. (2014). Development of the neurological hope index for multiple sclerosis (NHI-MS). In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 416). Retrieved from https://www.webofscience.com/
Experience of long-term use of non-invasive ventilation in motor neuron disease: an interpretative phenomenological analysis.
Ando, H., Chakrabarti, B., Angus, R. M., Cousins, R., Thornton, E. W., & Young, C. A. (2014). Experience of long-term use of non-invasive ventilation in motor neuron disease: an interpretative phenomenological analysis.. BMJ supportive & palliative care, 4(1), 50-56. doi:10.1136/bmjspcare-2013-000494
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis
Jones, A. R., Jivraj, N., Balendra, R., Murphy, C., Kelly, J., Thornhill, M., . . . Al-Chalabi, A. (2014). Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 15(3-4), 285-291. doi:10.3109/21678421.2013.872149
How do lower urinary tract symptoms affect quality of life in multiple sclerosis: a systematic review of the literature
Young, C. A., & Watson, H. L. (2014). How do lower urinary tract symptoms affect quality of life in multiple sclerosis: a systematic review of the literature. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 410). Retrieved from https://www.webofscience.com/
New sleep scales for multiple sclerosis
Mills, R. J., Tennant, A., & Young, C. A. (2014). New sleep scales for multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 418-419). Retrieved from https://www.webofscience.com/
Patient reported outcome measures for spasticity - comparison of psychometric properties and correlation with clinician assessment
Milinis, K., & Young, C. A. (2014). Patient reported outcome measures for spasticity - comparison of psychometric properties and correlation with clinician assessment. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 21 (pp. 238). Retrieved from https://www.webofscience.com/
Patient reported outcome measures for spasticity: comparison of psychometric properties and correlation with clinician assessment
Milinis, K., & Young, C. A. (2014). Patient reported outcome measures for spasticity: comparison of psychometric properties and correlation with clinician assessment. In JOURNAL OF NEUROLOGY Vol. 261 (pp. S164-S165). Retrieved from https://www.webofscience.com/
Psychosocial factors affecting quality of life in multiple sclerosis - a review of the current evidence base
Young, C. A., & Edwards, R. (2014). Psychosocial factors affecting quality of life in multiple sclerosis - a review of the current evidence base. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 405-406). Retrieved from https://www.webofscience.com/
Rasch analysis of the Leeds Spasticity Scale in multiple sclerosis
Mills, R. J., Milinis, K., Tennant, A., & Young, C. A. (2014). Rasch analysis of the Leeds Spasticity Scale in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 412). Retrieved from https://www.webofscience.com/
Rasch analysis of the WHO Disability Assessment Schedule 2.0 for use in multiple sclerosis
Gibbons, C. J., Mills, R., Tennant, A., & Young, C. (2014). Rasch analysis of the WHO Disability Assessment Schedule 2.0 for use in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 417). Retrieved from https://www.webofscience.com/
Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions
Milinis, K., & Young, C. A. (2014). Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions. In JOURNAL OF NEUROLOGY Vol. 261 (pp. S22). Retrieved from https://www.webofscience.com/
Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions
Milinis, K., & Young, C. A. (2014). Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 21 (pp. 28). Retrieved from https://www.webofscience.com/
The Penn State worry questionnaire provides a valid measure of worry across a broad range of disability in multiple sclerosis
Pomeroy, I., Tennant, A., & Young, C. A. (2014). The Penn State worry questionnaire provides a valid measure of worry across a broad range of disability in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL Vol. 20 (pp. 391-392). Retrieved from https://www.webofscience.com/
2013
Management of sialorrhoea in motor neuron disease: A survey of current UK practice
Hobson, E. V., McGeachan, A., Al-Chalabi, A., Chandran, S., Crawley, F., Dick, D., . . . McDermott, C. J. (2013). Management of sialorrhoea in motor neuron disease: A survey of current UK practice. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 14(7-8), 521-527. doi:10.3109/21678421.2013.790452
The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease
Gibbons, C., Thornton, E., Ealing, J., Shaw, P., Talbot, K., Tennant, A., & Young, C. (2013). The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 14(7-8), 537-545. doi:10.3109/21678421.2013.799700
Assessing social isolation in motor neurone disease: A Rasch analysis of the MND Social Withdrawal Scale
Gibbons, C. J., Thornton, E. W., Ealing, J., Shaw, P. J., Talbot, K., Tennant, A., & Young, C. A. (2013). Assessing social isolation in motor neurone disease: A Rasch analysis of the MND Social Withdrawal Scale. JOURNAL OF THE NEUROLOGICAL SCIENCES, 334(1-2), 112-118. doi:10.1016/j.jns.2013.08.002
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
Cudkowicz, M. E., van den Berg, L. H., Shefner, J. M., Mitsumoto, H., Mora, J. S., Ludolph, A., . . . EMPOWER investigators. (2013). Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.. The Lancet. Neurology, 12(11), 1059-1067. doi:10.1016/s1474-4422(13)70221-7
RASCH ANALYSIS OF THE WHOQOL-BREF IN POST POLIO SYNDROME
Pomeroy, I. M., Tennant, A., & Young, C. A. (2013). RASCH ANALYSIS OF THE WHOQOL-BREF IN POST POLIO SYNDROME. JOURNAL OF REHABILITATION MEDICINE, 45(9), 873-880. doi:10.2340/16501977-1186
Rasch analysis of the WHOQOL-BREF in post polio syndrome
Dphil, I. M. P., Tennant, A., & Young, C. A. (2013). Rasch analysis of the WHOQOL-BREF in post polio syndrome. Journal of Rehabilitation Medicine, 45(9), 873-880. doi:10.2340/16501977-1186
Tumefactive demyelination: an unusual cause of a spontaneously resolving homonymous hemianopia.
Dwivedi, R. A., Dwivedi, R. E., Durnian, J. M., & Young, C. A. (2013). Tumefactive demyelination: an unusual cause of a spontaneously resolving homonymous hemianopia.. BMJ case reports, 2013, bcr2013009363. doi:10.1136/bcr-2013-009363
Treatment of neuropathic pain for multiple sclerosis
Rog, D., Young, C. A., Hollis, S., & Friede, T. (n.d.). Treatment of neuropathic pain for multiple sclerosis. doi:10.1002/14651858.cd003736.pub2
Determinants of accepting non-invasive ventilation treatment in motor neurone disease: a quantitative analysis at point of need.
Cousins, R., Ando, H., Thornton, E., Chakrabarti, B., Angus, R., & Young, C. (2013). Determinants of accepting non-invasive ventilation treatment in motor neurone disease: a quantitative analysis at point of need.. Health psychology and behavioral medicine, 1(1), 47-58. doi:10.1080/21642850.2013.848169
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome
Comi, G., Martinelli, V., Rodegher, M., Moiola, L., Leocani, L., Bajenaru, O., . . . Filippi, M. (2013). Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome. MULTIPLE SCLEROSIS JOURNAL, 19(8), 1074-1083. doi:10.1177/1352458512469695
Evaluation of a Health State Staging System Defined by Loss of Independence in Amyotrophic Lateral Sclerosis: Assessment in a Second Dataset
Hammond, E., Young, C., Chio, A., Van den Berg, L., Al-Chalabi, A., Berry, J., . . . Kerr, D. (2013). Evaluation of a Health State Staging System Defined by Loss of Independence in Amyotrophic Lateral Sclerosis: Assessment in a Second Dataset. In NEUROLOGY Vol. 80. Retrieved from https://www.webofscience.com/
Inactivating AP1 transcription factor function in suprabasal epidermis produces a loricrin keratoderma phenotype associated with enhanced Th1 chemokine production
Young, C. A., Rorke, E. A., Babus, J., & Eckert, R. L. (2013). Inactivating AP1 transcription factor function in suprabasal epidermis produces a loricrin keratoderma phenotype associated with enhanced Th1 chemokine production. In JOURNAL OF INVESTIGATIVE DERMATOLOGY Vol. 133 (pp. S145). Retrieved from https://www.webofscience.com/
Is the Epworth Sleepiness Scale Suitable for Use in Stroke?
Mills, R. J., Koufali, M., Sharma, A., Tennant, A., & Young, C. A. (2013). Is the Epworth Sleepiness Scale Suitable for Use in Stroke?. TOPICS IN STROKE REHABILITATION, 20(6), 493-499. doi:10.1310/tsr2006-493
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
Allen, C., Counsell, C., Farrin, A., Al-Chalabi, A., Dickie, B., Leigh, P. N., . . . Majid, T. (2013). Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. LANCET NEUROLOGY, 12(4), 339-345. doi:10.1016/S1474-4422(13)700374
Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.
UKMND-LiCALS Study Group., Morrison, K. E., Dhariwal, S., Hornabrook, R., Savage, L., Burn, D. J., . . . Majid, T. (2013). Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.. The Lancet. Neurology, 12(4), 339-345. doi:10.1016/s1474-4422(13)70037-1
Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS)
Mills, R. J., Calabresi, M., Tennant, A., & Young, C. A. (2013). Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS). MULTIPLE SCLEROSIS JOURNAL, 19(4), 502-505. doi:10.1177/1352458512457840
Poststroke Fatigue: The Patient Perspective
Young, C. A., Mills, R. J., Gibbons, C., & Thornton, E. W. (2013). Poststroke Fatigue: The Patient Perspective. TOPICS IN STROKE REHABILITATION, 20(6), 478-484. doi:10.1310/tsr2006-478
Poststroke Fatigue: The Patient Perspective
Young, C. (2013). Poststroke Fatigue: The Patient Perspective. Topics in Stroke Rehabilitation, 20(6), 478-484. doi:10.1310/tscir2001-478
Production of a progressive symmetric erythrokeratoderma-like phenotype in the absence of nuclear loricrin accumulation
Rorke, E. A., Adhikary, G., Young, C. A., Roop, D. R., & Eckert, R. L. (2013). Production of a progressive symmetric erythrokeratoderma-like phenotype in the absence of nuclear loricrin accumulation. In JOURNAL OF INVESTIGATIVE DERMATOLOGY Vol. 133 (pp. S146). Retrieved from https://www.webofscience.com/
The Effect of Herpes Simplex Type-2 (Hsv-2) Suppression on Hepatitis C (HCV) Viral Load in Veterans With Hsv-2/HCV Co-Infection
Burton, M. J., Penman, A. D., Sunesara, I., Young, C. A., McGuire, B. M., & Hook, E. W. (2013). The Effect of Herpes Simplex Type-2 (Hsv-2) Suppression on Hepatitis C (HCV) Viral Load in Veterans With Hsv-2/HCV Co-Infection. In GASTROENTEROLOGY Vol. 144 (pp. S977). Retrieved from https://www.webofscience.com/
The patient experience of fatigue in motor neurone disease
Gibbons, C. J., Thornton, E. W., & Young, C. A. (2013). The patient experience of fatigue in motor neurone disease. FRONTIERS IN PSYCHOLOGY, 4. doi:10.3389/fpsyg.2013.00788
2012
Assessing and Managing Depression and Fatigue in Motor Neuron Disease
Gibbons, C. J., & Young, C. A. (2012). Assessing and Managing Depression and Fatigue in Motor Neuron Disease. Neurodegenerative Disease Management, 2(4), 401-409. doi:10.2217/nmt.12.42
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome
Meyniel, C., Spelman, T., Jokubaitis, V. G., Trojano, M., Izquierdo, G., Grand'Maison, F., . . . Butzkueven, H. (2012). Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. PLOS ONE, 7(6). doi:10.1371/journal.pone.0038661
Validation of the Neurological Fatigue Index for stroke (NFI-Stroke)
Mills, R. J., Pallant, J. F., Koufali, M., Sharma, A., Day, S., Tennant, A., & Young, C. A. (2012). Validation of the Neurological Fatigue Index for stroke (NFI-Stroke). HEALTH AND QUALITY OF LIFE OUTCOMES, 10. doi:10.1186/1477-7525-10-51
Erratum
Erratum (2012). Amyotrophic Lateral Sclerosis, 13(3), 331. doi:10.3109/17482968.2012.672118
Placebo-controlled trial of oral laquinimod for multiple sclerosis.
Comi, G., Jeffery, D., Kappos, L., Montalban, X., Boyko, A., Rocca, M. A., . . . ALLEGRO Study Group. (2012). Placebo-controlled trial of oral laquinimod for multiple sclerosis.. The New England journal of medicine, 366(11), 1000-1009. doi:10.1056/nejmoa1104318
147 The effects of relapses and disability on resource use in a multidisciplinary MS clinic
Pomeroy, I., Calabresi, M., & Young, C. A. (2012). 147 The effects of relapses and disability on resource use in a multidisciplinary MS clinic. Journal of Neurology, Neurosurgery & Psychiatry, 83(3), e1.100-e1. doi:10.1136/jnnp-2011-301993.189
How well do questionnaires capture symptomatic relief and well-being over time with NIV in motor neurone disease?
Ando, H., Chakrabarti, B., Young, C., Cousins, R., Thornton, E., & Angus, R. (2012). How well do questionnaires capture symptomatic relief and well-being over time with NIV in motor neurone disease?. In EUROPEAN RESPIRATORY JOURNAL Vol. 40. Retrieved from https://www.webofscience.com/
Rasch analysis of the Epworth Sleepiness Scale in patients with post-polio syndrome
Gibbons, C. J., Pomeroy, I. M., Tennant, A., & Young, C. A. (2012). Rasch analysis of the Epworth Sleepiness Scale in patients with post-polio syndrome. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 19 (pp. 263). Retrieved from https://www.webofscience.com/
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome
Young, C. A., Mills, R. J., Woolmore, J., Hawkins, C. P., & Tennant, A. (2012). The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome. MULTIPLE SCLEROSIS JOURNAL, 18(9), 1326-1333. doi:10.1177/1352458512436592
Uptake of NIV treatment in MND is dependent upon caregiver variables
Cousins, R., Ando, H., Young, C., Chakrabarti, B., & Angus, R. (2012). Uptake of NIV treatment in MND is dependent upon caregiver variables. In EUROPEAN RESPIRATORY JOURNAL Vol. 40. Retrieved from https://www.webofscience.com/
Work in progress: quality of life (QoL) and neurological disease - trajectories of outcome in neurological conditions (TONiC): a study protocol
Gibbons, C. J., Cousins, R., Pomeroy, I. M., Ando, H., Al-Chalabi, A., Chataway, J., . . . Young, C. A. (2012). Work in progress: quality of life (QoL) and neurological disease - trajectories of outcome in neurological conditions (TONiC): a study protocol. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 19 (pp. 264). Retrieved from https://www.webofscience.com/
2011
Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND)
Gibbons, C. J., Mills, R. J., Thornton, E. W., Ealing, J., Mitchell, J. D., Shaw, P. J., . . . Young, C. A. (2011). Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). HEALTH AND QUALITY OF LIFE OUTCOMES, 9. doi:10.1186/1477-7525-9-101
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
Freedman, M. S., Bar-Or, A., Oger, J., Traboulsee, A., Patry, D., Young, C., . . . Verco, T. (2011). A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS. NEUROLOGY, 77(16), 1551-1560. doi:10.1212/WNL.0b013e318233b240
Rasch analysis of the hospital anxiety and depression scale (hads) for use in motor neurone disease
Gibbons, C. J., Mills, R. J., Thornton, E. W., Ealing, J., Mitchell, J. D., Shaw, P. J., . . . Young, C. A. (2011). Rasch analysis of the hospital anxiety and depression scale (hads) for use in motor neurone disease. HEALTH AND QUALITY OF LIFE OUTCOMES, 9. doi:10.1186/1477-7525-9-82
Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]
Al-Chalabi, A., Shaw, P. J., Young, C. A., Morrison, K. E., Murphy, C., Thornhill, M., . . . Leigh, P. N. (2011). Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]. BMC NEUROLOGY, 11. doi:10.1186/1471-2377-11-111
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.
Khatri, B., Barkhof, F., Comi, G., Hartung, H. -P., Kappos, L., Montalban, X., . . . TRANSFORMS Study Group. (2011). Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.. The Lancet. Neurology, 10(6), 520-529. doi:10.1016/s1474-4422(11)70099-0
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis
Young, C. A., Ellis, C., Johnson, J., Sathasivam, S., & Pih, N. (2011). Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD006981.pub2
Comparing the Aspartate Aminotransferase (AST) to Platelet Ratio Index (APRI) Between African American and White Veterans with Chronic Hepatitis C
Burton, M. J., Sunesara, I., Penman, A., Pham, H., Oliver, N., Young, C. A., . . . McGuire, B. M. (2011). Comparing the Aspartate Aminotransferase (AST) to Platelet Ratio Index (APRI) Between African American and White Veterans with Chronic Hepatitis C. SOUTHERN MEDICAL JOURNAL, 104(5), 309-314. doi:10.1097/SMJ.0b013e318213cf52
Factors predisposing to the development of multiple sclerosis
Young, C. A. (2011). Factors predisposing to the development of multiple sclerosis. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 104(5), 383-386. doi:10.1093/qjmed/hcr012
Adverse cognitive effects of phenytoin in severe brain injury: A case report
Pinder, C., & Young, C. (2011). Adverse cognitive effects of phenytoin in severe brain injury: A case report. BRAIN INJURY, 25(6), 634-637. doi:10.3109/02699052.2011.572946
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.
Comi, G., Cohen, J. A., Arnold, D. L., Wynn, D., Filippi, M., & FORTE Study Group. (2011). Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.. Annals of neurology, 69(1), 75-82. doi:10.1002/ana.22316
Predictors of Confirmed Disability Progression after a First Demyelinating Event
Butzkueven, H., Spelman, T., Izquierdo, G., Grand-Maison, F., Trojano, M., Zwanikken, C., . . . Sirbu, C. (2011). Predictors of Confirmed Disability Progression after a First Demyelinating Event. In NEUROLOGY Vol. 76 (pp. A474-A475). Retrieved from https://www.webofscience.com/
Results from the 5-Year Prospective Follow-Up of Patients Receiving Glatiramer Acetate in the PreCISe Study on Delaying Conversion to CDMS
Martinelli, V., Comi, G., Rodegher, M., Moiola, L., Bajenaru, O., Carra, A., . . . Filippi, M. (2011). Results from the 5-Year Prospective Follow-Up of Patients Receiving Glatiramer Acetate in the PreCISe Study on Delaying Conversion to CDMS. In NEUROLOGY Vol. 76 (pp. A564-A565). Retrieved from https://www.webofscience.com/
The relationship between fatigue and other clinical features of multiple sclerosis
Mills, R. J., & Young, C. A. (2011). The relationship between fatigue and other clinical features of multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL, 17(5), 604-612. doi:10.1177/1352458510392262
2010
Future oral drug options for multiple sclerosis treatment
Young, C. (2010). Future oral drug options for multiple sclerosis treatment. Future Prescriber, 11(3), 12-15. doi:10.1002/fps.69
P156 Does analysis of patient-ventilator interaction offer benefits in addition to overnight pulse oximetry in patients with motor neurone disease being followed on non-invasive ventilation?
Chakrabarti, B., Ando, H., Thornton, E., Ford, V., Young, C. A., & Angus, R. M. (2010). P156 Does analysis of patient-ventilator interaction offer benefits in addition to overnight pulse oximetry in patients with motor neurone disease being followed on non-invasive ventilation?. Thorax, 65(Suppl 4), A144. doi:10.1136/thx.2010.151043.7
Bladder symptoms in multiple sclerosis: a review of pathophysiology and management
Nicholas, R., Young, C., & Friede, T. (2010). Bladder symptoms in multiple sclerosis: a review of pathophysiology and management. EXPERT OPINION ON DRUG SAFETY, 9(6), 905-915. doi:10.1517/14740338.2010.501793
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
Comi, G., Abramsky, O., Arbizu, T., Boyko, A., Gold, R., Havrdová, E., . . . LAQ/5063 Study Group. (2010). Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.. Multiple sclerosis (Houndmills, Basingstoke, England), 16(11), 1360-1366. doi:10.1177/1352458510378127
Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis
Mills, R. J., Young, C. A., Pallant, J. F., & Tennant, A. (2010). Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81(9), 1049-1051. doi:10.1136/jnnp.2008.151340
Disability after encephalitis: development and validation of a new outcome score
Lewthwaite, P., Begum, A., Ooi, M. H., Faragher, B., Lai, B. F., Sandaradura, I., . . . Solomon, T. (2010). Disability after encephalitis: development and validation of a new outcome score. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 88(8), 584-592. doi:10.2471/BLT.09.071357
Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3 T
Mills, R. J., Young, C. A., & Smith, E. T. (2010). Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3 T. BRITISH JOURNAL OF RADIOLOGY, 83(990), 493-498. doi:10.1259/bjr/65228893
Identifying poor adaptation to a new diagnosis of motor neuron disease: A pilot study into the value of an early patient-led interview
Hugel, H., Pih, N., Dougan, C. P., Rigby, S., & Young, C. A. (2010). Identifying poor adaptation to a new diagnosis of motor neuron disease: A pilot study into the value of an early patient-led interview. AMYOTROPHIC LATERAL SCLEROSIS, 11(1-2), 104-109. doi:10.3109/17482960902829205
The use of dry powder inhaler devices by elderly patients suffering from chronic obstructive pulmonary disease.
Quinet, P., Young, C. A., & Héritier, F. (2010). The use of dry powder inhaler devices by elderly patients suffering from chronic obstructive pulmonary disease.. Annals of physical and rehabilitation medicine, 53(2), 69-76. doi:10.1016/j.rehab.2009.11.001
Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS)
Mills, R. J., Young, C. A., Pallant, J. F., & Tennant, A. (2010). Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS). HEALTH AND QUALITY OF LIFE OUTCOMES, 8. doi:10.1186/1477-7525-8-22
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H. -P., Khatri, B. O., Montalban, X., . . . TRANSFORMS Study Group. (2010). Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.. The New England journal of medicine, 362(5), 402-415. doi:10.1056/nejmoa0907839
2009
Acute amnesia in MS revisited.
Larner, A. J., & Young, C. A. (2009). Acute amnesia in MS revisited.. International MS journal, 16(3), 102-104.
Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results
Giovannoni, G., Barbarash, O., Casset-Semanaz, F., King, J., Metz, L., Pardo, G., . . . Stubinski, B. (2009). Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results. MULTIPLE SCLEROSIS JOURNAL, 15(2), 219-228. doi:10.1177/1352458508097299
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
Comi, G., Martinelli, V., Rodegher, M., Moiola, L., Bajenaru, O., Carra, A., . . . Filippi, M. (2009). Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. LANCET, 374(9700), 1503-1511. doi:10.1016/S0140-6736(09)61259-9
Fornix damage from solitary subependymal giant cell astrocytoma causing postoperative amnesic syndrome
Ibrahim, I., Young, C. A., & Larner, A. J. (2009). Fornix damage from solitary subependymal giant cell astrocytoma causing postoperative amnesic syndrome. BRITISH JOURNAL OF HOSPITAL MEDICINE, 70(8), 478-479. doi:10.12968/hmed.2009.70.8.43545
The effects of an 'exercise and education' programme on exercise self-efficacy and levels of independent activity in adults with acquired neurological pathologies: an exploratory, randomized study
Haworth, J., Young, C., & Thornton, E. (2009). The effects of an 'exercise and education' programme on exercise self-efficacy and levels of independent activity in adults with acquired neurological pathologies: an exploratory, randomized study. CLINICAL REHABILITATION, 23(4), 371-3U2. doi:10.1177/0269215508101728
Anticholinergics for urinary symptoms in multiple sclerosis.
Nicholas, R. S., Friede, T., Hollis, S., & Young, C. A. (2009). Anticholinergics for urinary symptoms in multiple sclerosis.. The Cochrane database of systematic reviews, (1), CD004193. doi:10.1002/14651858.cd004193.pub2
Rasch analysis of the Fatigue Severity Scale in multiple sclerosis
Mills, R. J., Young, C. A., Nicholas, R. S., Pallant, J. F., & Tennant, A. (2009). Rasch analysis of the Fatigue Severity Scale in multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL, 15(1), 81-87. doi:10.1177/1352458508096215
Anticholinergics for urinary symptoms in multiple sclerosis
Nicholas, R. S., Friede, T., Hollis, S., & Young, C. A. (2009). Anticholinergics for urinary symptoms in multiple sclerosis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD004193.pub2
Identifying poor adaptation to a new diagnosis of motor neuron disease: A pilot study into the value of an early patient-led interview
Hugel, H., Pih, N., Dougan, C., Rigby, S., & Young, C. (n.d.). Identifying poor adaptation to a new diagnosis of motor neuron disease: A pilot study into the value of an early patient-led interview. Amyotrophic Lateral Sclerosis, 1-6. doi:10.1080/17482960902829205
2008
Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis
Mamutse, G., Woolmore, J., Pye, E., Partridge, J., Boggild, M., Young, C., . . . Hawkins, C. P. (2008). Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL, 14(9), 1280-1283. doi:10.1177/1352458508094643
A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis
Rigby, S. A., Thornton, E. W., & Young, C. A. (2008). A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 13, 619-631. doi:10.1348/135910707X241505
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Comi, G., Pulizzi, A., Rovaris, M., Abramsky, O., Arbizu, T., Boiko, A., . . . LAQ/5062 Study Group. (2008). Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.. Lancet (London, England), 371(9630), 2085-2092. doi:10.1016/s0140-6736(08)60918-6
Perceptions of goal setting in a neurological rehabilitation unit: A qualitative study of patients, carers and staff
Young, C. A., Manmathan, G. P., & Ward, J. C. R. (2008). Perceptions of goal setting in a neurological rehabilitation unit: A qualitative study of patients, carers and staff. JOURNAL OF REHABILITATION MEDICINE, 40(3), 190-194. doi:10.2340/16501977-0147
A familial syndrome of multiple sclerosis, early-onset dementia and epilepsy
Young, C. A., Boggild, M., & Larner, A. J. (2008). A familial syndrome of multiple sclerosis, early-onset dementia and epilepsy. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 15 (pp. 142). Retrieved from https://www.webofscience.com/
A medical definition of fatigue in multiple sclerosis
Mills, R. J., & Young, C. A. (2008). A medical definition of fatigue in multiple sclerosis. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 101(1), 49-60. doi:10.1093/qjmed/hcm122
Qualitative analysis of subjective experiences of fatigue in patients with myasthenia gravis
Gibbons, C. J., Drenckova-Kholsa, T., Mills, R. J., Hart, I. K., Thornton, E. W., & Young, C. A. (2008). Qualitative analysis of subjective experiences of fatigue in patients with myasthenia gravis. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 15 (pp. 153). Retrieved from https://www.webofscience.com/
Sporadic Creutzfeldt-Jakob disease in two adolescents
Murray, K., Ritchie, D. L., Bruce, M., Young, C. A., Doran, M., Ironside, J. W., & Will, R. G. (2008). Sporadic Creutzfeldt-Jakob disease in two adolescents. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 79(1), 14-18. doi:10.1136/jnnp.2006.104570
Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome: subgroup analyses
Comi, G., Carra, A., Fazekas, F., Rieckmann, P., Bajenaru, O., Hillert, J., . . . Filippi, M. (2008). Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome: subgroup analyses. In MULTIPLE SCLEROSIS JOURNAL Vol. 14 (pp. S38). Retrieved from https://www.webofscience.com/
2007
Minocycline for amyotrophic lateral sclerosis or motor neuron disease
Sathasivam, S., Addison-Jones, R., Miller, R. G., Moore, D. H., & Young, C. A. (n.d.). Minocycline for amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd006840
Oromucosal Δ<SUP>9</SUP>-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis:: An uncontrolled, open-label, 2-year extension trial
Rog, D. J., Nurmikko, T. J., & Young, C. A. (2007). Oromucosal Δ<SUP>9</SUP>-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis:: An uncontrolled, open-label, 2-year extension trial. CLINICAL THERAPEUTICS, 29(9), 2068-2079. doi:10.1016/j.clinthera.2007.09.013
Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2007). Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis. CLINICAL JOURNAL OF PAIN, 23(6), 473-481. doi:10.1097/AJP.0b013e31805d0c5d
307 LONG‐TERM USE OF SATIVEX IN MULTIPLE SCLEROSIS CENTRAL PAIN; DOSING AND CHANGES IN CONCOMITANT ANALGESIA
Rog, D. J., Nurmikko, T. J., Sarantis, N. S., & Young, C. A. (2007). 307 LONG‐TERM USE OF SATIVEX IN MULTIPLE SCLEROSIS CENTRAL PAIN; DOSING AND CHANGES IN CONCOMITANT ANALGESIA. European Journal of Pain, 11(S1). doi:10.1016/j.ejpain.2007.03.322
3D MRI in multiple sclerosis: a study of three sequences at 3 T
Mills, R. J., Young, C. A., & Smith, E. T. S. (2007). 3D MRI in multiple sclerosis: a study of three sequences at 3 T. BRITISH JOURNAL OF RADIOLOGY, 80(953), 307-320. doi:10.1259/bjr/52670770
Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial
Rovaris, M., Comi, G., Rocca, M. A., Valsasina, P., Ladkani, D., Pieri, E., . . . Filippi, M. (2007). Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trial. MULTIPLE SCLEROSIS, 13(4), 502-508. doi:10.1177/1352458506070704
Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation.
Woolmore, J. A., Stone, M., Pye, E. M., Partridge, J. M., Boggild, M., Young, C., . . . Strange, R. C. (2007). Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation.. Multiple sclerosis (Houndmills, Basingstoke, England), 13(3), 369-375. doi:10.1177/135245850607192
Perceptions of self-efficacy and rehabilitation among neurologically disabled adults
Dixon, G., Thornton, E. W., & Young, C. A. (2007). Perceptions of self-efficacy and rehabilitation among neurologically disabled adults. CLINICAL REHABILITATION, 21(3), 230-240. doi:10.1177/0269215506071784
Treatment for ataxia in multiple sclerosis.
Mills, R. J., Yap, L., & Young, C. A. (2007). Treatment for ataxia in multiple sclerosis.. The Cochrane database of systematic reviews, (1), CD005029. doi:10.1002/14651858.cd005029.pub2
Detection of hearing impairment and handicap in Paget's disease of bone using a simple scoring system: A case control study
Young, C. A., Fraser, W. D., & Mackenzie, I. J. (2007). Detection of hearing impairment and handicap in Paget's disease of bone using a simple scoring system: A case control study. BONE, 40(1), 189-193. doi:10.1016/j.bone.2006.07.001
Rasch analysis of the fatigue severity scale in multiple sclerosis
Mills, R. J., Nicholas, R. S., Malik, O., & Young, C. A. (2007). Rasch analysis of the fatigue severity scale in multiple sclerosis. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 14 (pp. 285). Retrieved from https://www.webofscience.com/
Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation
Woolmore, J. A., Stone, M., Pye, E. M., Partridge, J. M., Boggild, M., Young, C., . . . Strange, R. C. (2007). Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation. MULTIPLE SCLEROSIS, 13(3), 369-375. doi:10.1177/1352458506071292
The symptom of fatigue in spinal injury
Mills, R. J., Goodall, V., Thornton, E. W., & Young, C. A. (2007). The symptom of fatigue in spinal injury. In EUROPEAN JOURNAL OF NEUROLOGY Vol. 14 (pp. 159). Retrieved from https://www.webofscience.com/
Treatment for ataxia in multiple sclerosis
Mills, R. J., Yap, L., & Young, C. A. (2007). Treatment for ataxia in multiple sclerosis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD005029.pub2
2006
A randomized controlled trial of a health promotion education programme for people with multiple sclerosis
Ennis, M., Thain, J., Boggild, M., Baker, G. A., & Young, C. A. (2006). A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. CLINICAL REHABILITATION, 20(9), 783-792. doi:10.1177/0269215506070805
Circle of Willis variation in a complex stroke presentation: a case report
Emsley, H. C. A., Young, C. A., & White, R. P. (2006). Circle of Willis variation in a complex stroke presentation: a case report. BMC Neurology, 6(1). doi:10.1186/1471-2377-6-13
Tinnitus and Paget's disease of bone.
Mackenzie, I., Young, C., & Fraser, W. D. (2006). Tinnitus and Paget's disease of bone.. The Journal of laryngology and otology, 120(11), 899-902. doi:10.1017/s0022215106002519
476 A RANDOMISED CONTROLLED STUDY OF SATIVEX, A CANNABIS BASED MEDICINE, IN CENTRAL NEUROPATHIC PAIN DUE TO MULTIPLE SCLEROSIS
Young, C. A., Rog, D. J., & Sarantis, N. (2006). 476 A RANDOMISED CONTROLLED STUDY OF SATIVEX, A CANNABIS BASED MEDICINE, IN CENTRAL NEUROPATHIC PAIN DUE TO MULTIPLE SCLEROSIS. European Journal of Pain, 10(S1). doi:10.1016/s1090-3801(06)60479-5
How does current care practice influence the experience of a new diagnosis of motor neuron disease? A qualitative study of current guidelines-based practice
Hugel, H., Grundy, N., Rigby, S., & Young, C. A. (2006). How does current care practice influence the experience of a new diagnosis of motor neuron disease? A qualitative study of current guidelines-based practice. AMYOTROPHIC LATERAL SCLEROSIS, 7(3), 161-166. doi:10.1080/14660820600601051
Worries and concerns of patients with multiple sclerosis: development of an assessment scale
Thornton, E. W., Tedman, S., Rigby, S., Bashforth, H., & Young, C. (2006). Worries and concerns of patients with multiple sclerosis: development of an assessment scale. MULTIPLE SCLEROSIS, 12(2), 196-203. doi:10.1191/135248506ms1273oa
Circle of Willis variation in a complex stroke presentation: a case report
Emsley, H. C. A., Young, C. A., & White, R. P. (2006). Circle of Willis variation in a complex stroke presentation: a case report. BMC NEUROLOGY, 6. doi:10.1186/1471-2377-6-13
2005
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005). Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. NEUROLOGY, 65(6), 812-819. doi:10.1212/01.wnl.0000176753.45410.8b
A randomised controlled trial of cannabis based medicinal extract in central neuropathic pain due to multiple sclerosis
Young, C., Nurmikko, T., & Rog, D. (2005). A randomised controlled trial of cannabis based medicinal extract in central neuropathic pain due to multiple sclerosis. The Journal of Pain, 6(3), S38. doi:10.1016/j.jpain.2005.01.147
2004
Treatment for ataxia in multiple sclerosis
Mills, R. J., Friede, T., & Young, C. A. (n.d.). Treatment for ataxia in multiple sclerosis. In R. Mills (Ed.). John Wiley & Sons, Ltd. doi:10.1002/14651858.cd005029
2003
Aids, orthoses, and environmental control systems
Young, C. A. (2003). Aids, orthoses, and environmental control systems. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74, 13-17. Retrieved from https://www.webofscience.com/
HANDBOOK OF NEUROLOGICAL REHABILITATION, 2ND EDITION
Young, C. A. (n.d.). HANDBOOK OF NEUROLOGICAL REHABILITATION, 2ND EDITION. Brain, 126(10), 2335-2337. doi:10.1093/brain/awg280
A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment
Craig, J., Young, C. A., Ennis, M., Baker, G., & Boggild, M. (2003). A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74(9), 1225-1230. doi:10.1136/jnnp.74.9.1225
A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment
Craig, J. (2003). A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. Journal of Neurology, Neurosurgery & Psychiatry, 74(9), 1225-1230. doi:10.1136/jnnp.74.9.1225
Use of, and outputs from, an assault patient questionnaire within accident and emergency departments on Merseyside
Young, C. A., & Douglass, J. P. (2003). Use of, and outputs from, an assault patient questionnaire within accident and emergency departments on Merseyside. EMERGENCY MEDICINE JOURNAL, 20(3), 232-237. doi:10.1136/emj.20.3.232
Anticholinergics for urinary symptoms in multiple sclerosis
Nicholas, R. S., Friede, T., Hollis, S., & Young, C. A. (n.d.). Anticholinergics for urinary symptoms in multiple sclerosis. In R. Nicholas (Ed.). John Wiley & Sons, Ltd. doi:10.1002/14651858.cd004193
Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale
Rigby, S. A., Domenech, C., Thornton, E. W., Tedman, S., & Young, C. A. (2003). Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale. MULTIPLE SCLEROSIS JOURNAL, 9(1), 73-81. doi:10.1191/1352458503ms870oa
A controlled trial of natalizumab for relapsing multiple sclerosis.
Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P. A., Libonati, M. A., . . . O'Connor, P. W. (2003). A controlled trial of natalizumab for relapsing multiple sclerosis.. NEW ENGLAND JOURNAL OF MEDICINE, 348(1), 15-23. doi:10.1056/NEJMoa020696
Assessment of health needs in multidisciplinary care
Young, C. A. (2003). Assessment of health needs in multidisciplinary care. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 74(1), 5. doi:10.1136/jnnp.74.1.5
PERIPHERAL BONE MASS DENSITY AND ABSORPTION MARKERS IN MULTIPLE SCLEROSIS
Clewes, A., Young, C. A., Birkenshaw, G., & Fraser, W. D. (2003). PERIPHERAL BONE MASS DENSITY AND ABSORPTION MARKERS IN MULTIPLE SCLEROSIS. In RHEUMATOLOGY Vol. 42 (pp. 113-114). Retrieved from https://www.webofscience.com/
Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis
Rovaris, M., Comi, G., Ladkani, D., Wolinsky, J. S., & Filippi, M. (2003). Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis. AMERICAN JOURNAL OF NEURORADIOLOGY, 24(1), 75-81. Retrieved from https://www.webofscience.com/
2002
An unusual epistaxis.
Saunders, S., & Young, C. (2002). An unusual epistaxis.. Postgraduate medical journal, 78(924), 619-620. doi:10.1136/pmj.78.924.619
A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis
Wade, D. T., Young, C. A., Chaudhuri, K. R., & Davidson, D. L. W. (2002). A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73(3), 246-249. doi:10.1136/jnnp.73.3.246
2001
Treatment of neuropathic pain for multiple sclerosis
Rog, D., Young, C. A., Hollis, S., & Friede, T. (n.d.). Treatment of neuropathic pain for multiple sclerosis. In D. Rog (Ed.). John Wiley & Sons, Ltd. doi:10.1002/14651858.cd003736
Quality of life issues in motor neurone disease: the development and validation of a coping strategies questionnaire, the MND Coping Scale
Lee, J. N., Rigby, S. A., Burchardt, F., Thornton, E. W., Dougan, C., & Young, C. A. (2001). Quality of life issues in motor neurone disease: the development and validation of a coping strategies questionnaire, the MND Coping Scale. JOURNAL OF THE NEUROLOGICAL SCIENCES, 191(1-2), 79-85. doi:10.1016/S0022-510X(01)00619-0
Short-term brain volume change in relapsing-remitting multiple sclerosis - Effect of glatiramer acetate and implications
Rovaris, M., Comi, G., Rocca, M. A., Wolinsky, J. S., & Filippi, M. (2001). Short-term brain volume change in relapsing-remitting multiple sclerosis - Effect of glatiramer acetate and implications. BRAIN, 124, 1803-1812. doi:10.1093/brain/124.9.1803
Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data.
Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data. (2001). Multiple sclerosis (Houndmills, Basingstoke, England), 7(3), 179-183. doi:10.1177/135245850100700308
Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale
Airlie, J., Baker, G. A., Smith, S. J., & Young, C. A. (2001). Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale. CLINICAL REHABILITATION, 15(3), 259-265. doi:10.1191/026921501668362643
HLA-DRB1 and disease outcome in multiple sclerosis
Weatherby, S. J. M., Thomson, W., Pepper, L., Donn, R., Worthington, J., Mann, C. L. A., . . . Hawkins, C. P. (2001). HLA-DRB1 and disease outcome in multiple sclerosis. JOURNAL OF NEUROLOGY, 248(4), 304-310. doi:10.1007/s004150170205
Anti-spasticity agents for multiple sclerosis.
Shakespeare, D. T., Boggild, M., & Young, C. (2001). Anti-spasticity agents for multiple sclerosis.. The Cochrane database of systematic reviews, (4), CD001332. doi:10.1002/14651858.cd001332
Double-blind randomized multicenter dose-comparison study of interferon-β-1a (AVONEX):: rationale, design and baseline data
Kristoferitsch, W., Seeldrayers, P., Kyriallis, K., Brochet, B., Confavreux, C., Clanet, M., . . . Keane, R. (2001). Double-blind randomized multicenter dose-comparison study of interferon-β-1a (AVONEX):: rationale, design and baseline data. MULTIPLE SCLEROSIS, 7(3), 179-183. Retrieved from https://www.webofscience.com/
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis
Comi, G., Filippi, M., & Wolinsky, J. S. (2001). European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis. ANNALS OF NEUROLOGY, 49(3), 290-297. doi:10.1002/ana.64
2000
Development of a patient-specific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS)
Dougan, C. F., Connell, C. O., Thornton, E., & Young, C. A. (2000). Development of a patient-specific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS). JOURNAL OF THE NEUROLOGICAL SCIENCES, 180(1-2), 86-93. doi:10.1016/S0022-510X(00)00415-9
Glutathione S-transferase polymorphisms in MS - Their relationship to disability
Mann, C. L. A., Davies, M. B., Boggild, M. D., Alldersea, J., Fryer, A. A., Jones, P. W., . . . Hawkins, C. P. (2000). Glutathione S-transferase polymorphisms in MS - Their relationship to disability. NEUROLOGY, 54(3), 552-557. doi:10.1212/WNL.54.3.552
Anti-spasticity agents for multiple sclerosis.
Shakespeare, D. T., Young, C. A., & Boggild, M. (2000). Anti-spasticity agents for multiple sclerosis.. The Cochrane database of systematic reviews, (4), CD001332. doi:10.1002/14651858.cd001332
Anti-spasticity agents for multiple sclerosis.
Shakespeare, D. T., Boggild, M., & Young, C. (2003). Anti-spasticity agents for multiple sclerosis.. The Cochrane database of systematic reviews, (4), CD001332. doi:10.1002/14651858.cd001332
Multiple sclerosis: care needs for 2000 and beyond
Nodder, D., Chappell, B., Bates, D., Freeman, J., Hatch, J., Keen, J., . . . Young, C. (2000). Multiple sclerosis: care needs for 2000 and beyond. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 93(5), 219-224. doi:10.1177/014107680009300502
Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis
Weatherby, S. J. M., Mann, C. L. A., Davies, M. B., Carthy, D., Fryer, A. A., Boggild, M. D., . . . Hawkins, C. P. (2000). Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis. MULTIPLE SCLEROSIS, 6(1), 32-36. doi:10.1191/135245800678827464
The role of affect on the perception of disability in multiple sclerosis
Smith, S. J., & Young, C. A. (2000). The role of affect on the perception of disability in multiple sclerosis. CLINICAL REHABILITATION, 14(1), 50-54. doi:10.1191/026921500676724210
1999
Quality of life assessment in MND: development of a Social Withdrawal Scale
Rigby, S. A., Thornton, E. W., Tedman, S., Burchardt, F., Young, C. A., & Dougan, C. (1999). Quality of life assessment in MND: development of a Social Withdrawal Scale. JOURNAL OF THE NEUROLOGICAL SCIENCES, 169(1-2), 26-34. doi:10.1016/S0022-510X(99)00212-9
The effect of anti-α4 integrin antibody on brain lesion activity in MS
Tubridy, N., Behan, P. O., Capildeo, R., Chaudhuri, A., Forbes, R., Hawkins, C. P., . . . Miller, D. H. (1999). The effect of anti-α4 integrin antibody on brain lesion activity in MS. NEUROLOGY, 53(3), 466-472. doi:10.1212/WNL.53.3.466
1998
Building a care and research team
Young, C. A. (1998). Building a care and research team. JOURNAL OF THE NEUROLOGICAL SCIENCES, 160, S137-S140. doi:10.1016/S0022-510X(98)00213-5
Quality of life in multiple sclerosis in France, Germany, and the United Kingdom
Murphy, N., Confavreux, C., Haas, J., König, N., Roullet, E., Sailer, M., . . . Yeardley, H. (1998). Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 65(4), 460-466. doi:10.1136/jnnp.65.4.460
Quality of life in multiple sclerosis in France, Germany, and the United Kingdom
Murphy, N., Confavreux, C., Haas, J., Konig, N., Roullet, E., Sailer, M., . . . J-L, M. (1998). Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. Journal of Neurology, Neurosurgery & Psychiatry, 65(4), 460-466. doi:10.1136/jnnp.65.4.460
Compression garments: Influence on muscle fatigue
Kraemer, W. J., Bush, J. A., Triplett-McBride, N. T., Koziris, L. P., Mangino, L. C., Fry, A. C., . . . Newton, R. U. (1998). Compression garments: Influence on muscle fatigue. JOURNAL OF STRENGTH AND CONDITIONING RESEARCH, 12(4), 211-215. Retrieved from https://www.webofscience.com/
Economic evaluation of multiple sclerosis in the UK, Germany and France
Murphy, N., Confavreux, C., Haas, J., Konig, N., Roullet, E., Sailer, M., . . . Merot, J. L. (1998). Economic evaluation of multiple sclerosis in the UK, Germany and France. PHARMACOECONOMICS, 13(5), 607-622. doi:10.2165/00019053-199813050-00013
1997
Overdiagnosis of TIA and minor stroke: experience at a regional neurovascular clinic.
Martin, P. J., Young, G., Enevoldson, T. P., & Humphrey, P. R. (1997). Overdiagnosis of TIA and minor stroke: experience at a regional neurovascular clinic.. QJM : monthly journal of the Association of Physicians, 90(12), 759-763. doi:10.1093/qjmed/90.12.759
Assessment of depression in patients with motor neuron disease and other neurologically disabling illness
Tedman, B. M., Young, C. A., & Williams, I. R. (1997). Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. JOURNAL OF THE NEUROLOGICAL SCIENCES, 152, S75-S79. doi:10.1016/S0022-510X(97)00249-9
1996
The District General Hospital as a Resource for the Provision of Neurological Services.
Boggild, M. D., Bowden, A. N., Chadwick, D. W., Doran, M., Enevoldson, T., Fletcher, N. A., . . . Young, C. A. (1996). The District General Hospital as a Resource for the Provision of Neurological Services.. Journal of the Royal College of Physicians of London, 30(5), 478-479.
Acitretin-induced myopathy
Lister, R. K., Lecky, B. R. F., LewisJones, M. S., & Young, C. A. (1996). Acitretin-induced myopathy. BRITISH JOURNAL OF DERMATOLOGY, 134(5), 989-990. doi:10.1111/j.1365-2133.1996.tb06350.x
''Evolutionary'' stable strategy of handedness in major league baseball
Goldstein, S. R., & Young, C. A. (1996). ''Evolutionary'' stable strategy of handedness in major league baseball. JOURNAL OF COMPARATIVE PSYCHOLOGY, 110(2), 164-169. Retrieved from https://www.webofscience.com/
1995
CENTRAL PONTINE MYELINOLYSIS - CLINICAL AND MRI CORRELATES
MARTIN, P. J., & YOUNG, C. A. (1995). CENTRAL PONTINE MYELINOLYSIS - CLINICAL AND MRI CORRELATES. POSTGRADUATE MEDICAL JOURNAL, 71(837), 430-432. doi:10.1136/pgmj.71.837.430
OBSTRUCTIVE SLEEP-APNEA WITH ARNOLD-CHIARI MALFORMATION
DOHERTY, M. J., SPENCE, D. P. S., YOUNG, C., & CALVERLEY, P. M. A. (1995). OBSTRUCTIVE SLEEP-APNEA WITH ARNOLD-CHIARI MALFORMATION. THORAX, 50(6), 690-691. doi:10.1136/thx.50.6.690
DISEASE PROGRESSION AND PERCEPTIONS OF HEALTH IN PATIENTS WITH MOTOR-NEURON DISEASE
YOUNG, C. A., TEDMAN, B. M., & WILLIAMS, I. R. (1995). DISEASE PROGRESSION AND PERCEPTIONS OF HEALTH IN PATIENTS WITH MOTOR-NEURON DISEASE. JOURNAL OF THE NEUROLOGICAL SCIENCES, 129, 50-53. doi:10.1016/0022-510X(95)00062-7
1993
Opsoclonus-myoclonus syndrome: an autopsy study of three cases.
Young, C. A., MacKenzie, J. M., Chadwick, D. W., & Williams, I. R. (1993). Opsoclonus-myoclonus syndrome: an autopsy study of three cases.. The European journal of medicine, 2(4), 239-241.
1992
SHORT-TERM-MEMORY IMPAIRMENT IN AN ALERT PATIENT AS A PRESENTATION OF HERPES-SIMPLEX ENCEPHALITIS
YOUNG, C. A., HUMPHREY, P. R. D., GHADIALI, E. J., KLAPPER, P. E., & CLEATOR, G. M. (1992). SHORT-TERM-MEMORY IMPAIRMENT IN AN ALERT PATIENT AS A PRESENTATION OF HERPES-SIMPLEX ENCEPHALITIS. NEUROLOGY, 42(1), 260-261. doi:10.1212/WNL.42.1.260
1991
EXTRACRANIAL VERTEBRAL ARTERY DISSECTION FOLLOWING TONIC-CLONIC SEIZURE
YOUNG, C. A., CHADWICK, D. W., & HUMPHREY, P. R. D. (1991). EXTRACRANIAL VERTEBRAL ARTERY DISSECTION FOLLOWING TONIC-CLONIC SEIZURE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 54(4), 365-366. doi:10.1136/jnnp.54.4.365
UNRECOGNIZED CUSHINGS-SYNDROME AND ADRENAL SUPPRESSION DUE TO TOPICAL CLOBETASOL PROPIONATE
YOUNG, C. A., WILLIAMS, I. R., & MACFARLANE, I. A. (1991). UNRECOGNIZED CUSHINGS-SYNDROME AND ADRENAL SUPPRESSION DUE TO TOPICAL CLOBETASOL PROPIONATE. BRITISH JOURNAL OF CLINICAL PRACTICE, 45(1), 61-62. Retrieved from https://www.webofscience.com/
1989
ATRIAL NATRIURETIC FACTOR DURING THE PERINATAL-PERIOD - EQUAL DEPLETION IN BOTH ATRIA
DOLAN, L. M., YOUNG, C. A., KHOURY, J. C., & DOBROZSI, D. J. (1989). ATRIAL NATRIURETIC FACTOR DURING THE PERINATAL-PERIOD - EQUAL DEPLETION IN BOTH ATRIA. PEDIATRIC RESEARCH, 25(4), 339-341. doi:10.1203/00006450-198904000-00005
1980
ARE HMO ENROLLEES BEING ATTRACTED BY A LIBERAL MATERNITY BENEFIT
HUDES, J., YOUNG, C. A., SOHRAB, L., & TRINH, C. N. (1980). ARE HMO ENROLLEES BEING ATTRACTED BY A LIBERAL MATERNITY BENEFIT. MEDICAL CARE, 18(6), 635-648. doi:10.1097/00005650-198006000-00006
1978
COMPARISON OF 1960 AND 1973-1974 EARLY NEONATAL-MORTALITY IN SELECTED STATES
KLEINMAN, J. C., KOVAR, M. G., FELDMAN, J. J., & YOUNG, C. A. (1978). COMPARISON OF 1960 AND 1973-1974 EARLY NEONATAL-MORTALITY IN SELECTED STATES. AMERICAN JOURNAL OF EPIDEMIOLOGY, 108(6), 454-469. doi:10.1093/oxfordjournals.aje.a112644
1966
COMPLICATIONS ASSOCIATED WITH WEARING OF CONTACT LENSES
DIXON, J. M., YOUNG, C. A., BALDONE, J. A., HALBERG, G. P., SAMPSON, W., & STONE, W. (1966). COMPLICATIONS ASSOCIATED WITH WEARING OF CONTACT LENSES. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 195(11), 901-&. doi:10.1001/jama.195.11.901
1961
SYRINGOMYELIA WITH MULTIPLE NEUROPATHIC JOINTS
YOUNG, C. A. (1961). SYRINGOMYELIA WITH MULTIPLE NEUROPATHIC JOINTS. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 54(7), 593. doi:10.1177/003591576105400716
PROLAPSE OF IRIS IN SENILE CATARACT EXTRACTION AND ITS PREVENTION
PFLUGER, E., DIETTRIC, H. G., & YOUNG, C. A. (1961). PROLAPSE OF IRIS IN SENILE CATARACT EXTRACTION AND ITS PREVENTION. SOUTHERN MEDICAL JOURNAL, 54(1), 61-&. Retrieved from https://www.webofscience.com/
1960
CAVERNOUS HAEMANGIOMATA
YOUNG, C. A. (1960). CAVERNOUS HAEMANGIOMATA. In PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON Vol. 53 (pp. 380). Retrieved from https://www.webofscience.com/